Study explores intratumoral microbiota as a novel frontier in cancer research

Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.

Brise raises $20M; Taro shareholder criticizes Sun Pharma deal

Plus, news about Tarsus Pharmaceuticals and Biohaven: Brise Pharmaceuticals raises $20M: The funding comes from Shunxi Fund, Sherpa Healthcare Partners and Qiming Ventures, among other

April 24, 2024

EPA restricts cancer-causing chemical used to sterilize medical devices

On Thursday, the Environmental Protection Agency finalized limits on a carcinogenic gas called ethylene oxide that is used to sterilize most medical devices. Sterilizing facilities

March 14, 2024

Public health strategies skip patients with rare diseases, says UK study – Pharmaceutical Technology

The study found eight rare diseases associated with increased risk of Covid-19-related mortality. Credit: imageBROKER/Berit Kessler via Getty Images. Researchers in the UK are calling

February 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.